IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,885 | -69.8% | 1,338 | -66.7% | 0.00% | -100.0% |
| Q2 2023 | $42,709 | +27.9% | 4,014 | +26.5% | 0.00% | 0.0% |
| Q1 2023 | $33,380 | +646.3% | 3,173 | +778.9% | 0.00% | – |
| Q4 2022 | $4,473 | -10.5% | 361 | -20.5% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 454 | -41.5% | 0.00% | – |
| Q2 2022 | $9,000 | +50.0% | 776 | +68.3% | 0.00% | – |
| Q1 2022 | $6,000 | +20.0% | 461 | +9.8% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 420 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 420 | -19.1% | 0.00% | – |
| Q2 2021 | $7,000 | +40.0% | 519 | +27.2% | 0.00% | – |
| Q1 2021 | $5,000 | +66.7% | 408 | +61.3% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 253 | -7.3% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 273 | +326.6% | 0.00% | – |
| Q2 2020 | $1,000 | – | 64 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
| 13D Management LLC | 533,562 | $5,613,073 | 2.85% |
| Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
| Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
| Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
| Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
| Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
| Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
| EMC Capital Management | 43,315 | $456 | 0.38% |
| Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |